Home
Abstract
My Abstract(s)
Login
ePosters
Back
Final Presentation Format
Podium Abstract
Eposter Presentation
Eposter in PDF Format
Accept format: PDF. The file size should not be more than 5MB
Eposter in Image Format
Accept format: PNG/JPG/WEBP. The file size should not be more than 2MB
Presentation Date / Time
Submission Status
Submitted
Abstract
Abstract Title
A comparison between the Australian Cancer Council optimal care pathway for men with prostate cancer and the actual care in a public tertiary centre in Australia
Presentation Type
Podium Abstract
Manuscript Type
Clinical Research
Abstract Category *
Oncology: Prostate
Author's Information
Number of Authors (including submitting/presenting author) *
2
No more than 10 authors can be listed (as per the Good Publication Practice (GPP) Guidelines).
Please ensure the authors are listed in the right order.
Country
Australia
Co-author 1
Thomas Milton Thomas.Milton@sa.gov.au Royal Adelaide Hospital Department of Surgery Adelaide Australia *
Co-author 2
Sophie Otto Sophie.Otto@sa.gov.au Royal Adelaide Hospital Department of Surgery Adelaide Australia -
Co-author 3
-
Co-author 4
-
Co-author 5
-
Co-author 6
-
Co-author 7
-
Co-author 8
-
Co-author 9
-
Co-author 10
-
Co-author 11
Co-author 12
Co-author 13
Co-author 14
Co-author 15
Co-author 16
Co-author 17
Co-author 18
Co-author 19
Co-author 20
Abstract Content
Introduction
The Australian Cancer Council provides an ‘optimal care pathway for men with prostate cancer’ guideline for the standard of care for patients. The guidelines give a timeframe in which the investigations, diagnosis, staging and treatment should be completed. The optimal care pathway recommends that patients should be seen by a Urologist within 4 weeks of referral, the MRI, prostate biopsy, and staging should be completed within 4 weeks initial appointment and treatment should be commenced within 3 months. The objective of this study was to determine how a large, tertiary public hospital in Australia compares to the optimal care pathway in providing timely care.
Materials and Methods
A retrospective audit was completed for all patients who underwent a robotic-assisted laparoscopic prostatectomy (RALP) in 2024 at this institution. For each patient, the date of the referral, booking for prostate biopsy, booking for RALP and date of RALP was recorded. The recorded data was then directly compared to the recommended durations in the optimal care pathway.
Results
There were 83 patients who had a RALP for prostate cancer in 2024. The average number of days between the referral and booking a prostate biopsy was 91 days, between booking and having the biopsy was 77 days, between the biopsy and booking the RALP was 77 days and between booking and having the RALP was 137 days. The total number of days between referral and having a RALP was 382 days. The initial appointment following referral at our institution was 63 days longer than recommended, the time to complete the investigations was 126 days longer and the time to RALP was 47 days longer. In total, from referral to RALP, it took an extra 236 days than what is recommended in the optimal care pathway.
Conclusions
The time it took to manage prostate cancer at this institution was significantly longer than what is recommended in the optimal care pathway by the Australian Cancer Council.
Keywords
Prostate cancer, RALP, public health
Figure 1
https://storage.unitedwebnetwork.com/files/1237/ba8242b90d1e2d7ced915163b8137710.jpg
Figure 1 Caption
Figure 1: A comparison between the Australian Cancer Council optimal care pathway for men with prostate cancer and the actual care in a public tertiary centre in Australia
Figure 2
Figure 2 Caption
Figure 3
Figure 3 Caption
Figure 4
Figure 4 Caption
Figure 5
Figure 5 Caption
Character Count
1917
Vimeo Link
Presentation Details
Session
Free Paper Podium(14): Oncology Prostate (D)
Date
Aug. 16 (Sat.)
Time
14:24 - 14:30
Presentation Order
10